Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Childhood cancer survival rates have soared over the past four decades, rising from 60% to 90% between 1975 and 2017, according to a new study in the Journal of the National Cancer Institute. The biggest gains were seen in acute lymphoblastic leukemia, while solid tumors improved more modestly. However, non-Hispanic Black children still face the lowest survival rates across multiple cancers, highlighting persistent disparities that researchers say must be urgently addressed.
Childhood cancer survival has come a long way — but not equally for everyone. A new study published in the Journal of the National Cancer Institute tracked survival trends among children and adolescents diagnosed with cancer in the U.S. from 1975 to 2022, drawing on data from over 150,000 patients. The headline finding: 5-year overall survival climbed from 60% to 90% between 1975 and 2017, a remarkable testament to decades of medical progress.
The gains weren't uniform across cancer types. Acute lymphoblastic leukemia (ALL) saw the most dramatic improvements, while solid tumors lagged behind. For some cancers like Hodgkin lymphoma, mortality risks persisted well beyond the 20-year mark — a reminder that "survival" doesn't always mean "cured."
Perhaps most concerning, non-Hispanic Black children had the lowest 5-year survival rates across multiple cancer types, even after accounting for age and decade of diagnosis.
Key Takeaways:
Why it matters: While the overall survival trend is a major win for pediatric oncology, the persistent racial gap signals that medical advances aren't reaching all children equally. Researchers point to a complex mix of factors — access to care, insurance, geography, tumor biology, and treatment side effects — as likely contributors, underscoring the need for targeted interventions to ensure every child benefits.